# the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia

> **NCT02279342** · PHASE4 · TERMINATED · sponsor: **Yokohama City University Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Febuxostat

## Key facts

- **NCT ID:** NCT02279342
- **Lead sponsor:** Yokohama City University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Entry were insufficient as expected.
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279342, "the Effect of Febuxostat on Coronary Plaque Volume in Patients With Chronic Stable Angina and Hyperuricemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02279342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*